Actively Recruiting
Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression
Led by Amsterdam UMC, location VUmc · Updated on 2024-01-16
11000
Participants Needed
6
Research Sites
287 weeks
Total Duration
On this page
Sponsors
A
Amsterdam UMC, location VUmc
Lead Sponsor
A
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The VASCULAID-RETRO study, within the broader VASCULAID project, aims to create artificial intelligence (AI) algorithms that can predict cardiovascular events and the progression of abdominal aortic aneurysm (AAA) and peripheral arterial disease (PAD). The study plans to gather and analyze data from at least 5000 AAA and 6000 PAD patients, combining existing cohorts and retrospectively collected data. During this project, AI tools will be developed to perform automatic anatomical segmentation and analyses on multimodal imaging. AI prediction algorithms will be developed based on multisource data (imaging, medical history, -omics).
CONDITIONS
Official Title
Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males and females aged 40 to 90 years with an abdominal aortic aneurysm larger than 3 cm, including infrarenal, juxtarenal, suprarenal, iliac (1.5 times normal diameter), or mycotic aneurysms
- Patients with AAA who have had interventions or ruptures
- Males and females aged 40 to 90 years with peripheral arterial disease at any Fontaine stage (1 to 4)
You will not qualify if you...
- Patients with aneurysms located in the ascending, thoracic, or thoracoabdominal (type 1-3) regions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Hospital District of Helsinki and Uusimaa (HUS)
Helsinki, Finland
Actively Recruiting
2
Asklepios kliniken hamburg
Hamburg, Germany
Actively Recruiting
3
Amsterdam UMC
Amsterdam, Netherlands
Actively Recruiting
4
University Hospital Center of São João
Porto, Portugal
Actively Recruiting
5
University Clinical Centre of Serbia
Belgrade, Serbia
Actively Recruiting
6
Oxford University Hospitals
Oxford, United Kingdom
Actively Recruiting
Research Team
K
Kak Khee Yeung, MD, PhD
CONTACT
L
Lotte Rijken, Msc.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here